These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 25472646

  • 1. Surgical Outcomes of Hepatic Resection for Hepatitis B Virus Surface Antigen-Negative and Hepatitis C Virus Antibody-Negative Hepatocellular Carcinoma.
    Yamashita Y, Imai D, Bekki Y, Kimura K, Matsumoto Y, Nakagawara H, Ikegami T, Yoshizumi T, Shirabe K, Aishima S, Maehara Y.
    Ann Surg Oncol; 2015 Jul; 22(7):2279-85. PubMed ID: 25472646
    [Abstract] [Full Text] [Related]

  • 2. Impact of Hepatic Steatosis on Disease-Free Survival in Patients with Non-B Non-C Hepatocellular Carcinoma Undergoing Hepatic Resection.
    Nishio T, Hatano E, Sakurai T, Taura K, Okuno M, Kasai Y, Seo S, Yasuchika K, Mori A, Kaido T, Uemoto S.
    Ann Surg Oncol; 2015 Jul; 22(7):2226-34. PubMed ID: 25395147
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection.
    Li T, Qin LX, Gong X, Zhou J, Sun HC, Qiu SJ, Ye QH, Wang L, Fan J.
    Cancer; 2013 Jan 01; 119(1):126-35. PubMed ID: 22736338
    [Abstract] [Full Text] [Related]

  • 4. Clinicopathologic Features and Outcomes of Non-B, Non-C Hepatocellular Carcinoma After Hepatectomy.
    Takeishi K, Maeda T, Shirabe K, Tsujita E, Yamashita Y, Harimoto N, Itoh S, Ikegami T, Yoshizumi T, Maehara Y.
    Ann Surg Oncol; 2015 Dec 01; 22 Suppl 3():S1116-24. PubMed ID: 26159442
    [Abstract] [Full Text] [Related]

  • 5. Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: a retrospective study of patients undergoing hepatic resection.
    Yokoi Y, Suzuki S, Baba S, Inaba K, Konno H, Nakamura S.
    J Gastroenterol; 2005 Mar 01; 40(3):274-82. PubMed ID: 15830287
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical characteristics and prognosis of non-B, non-C hepatocellular carcinoma: The impact of patient sex on disease-free survival - A retrospective cohort study.
    Hashimoto M, Tashiro H, Kobayashi T, Kuroda S, Hamaoka M, Ohdan H.
    Int J Surg; 2017 Mar 01; 39():206-213. PubMed ID: 28159713
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Outcomes after hepatectomy of patients with positive HBcAb Non-B Non-C hepatocellular carcinoma compared to overt hepatitis B virus hepatocellular carcinoma.
    Wu SS, Shan QY, Xie WX, Chen B, Huang Y, Guo Y, Xie XY, Lu MD, Peng BG, Kuang M, Shen SL, Wang W.
    Clin Transl Oncol; 2020 Mar 01; 22(3):401-410. PubMed ID: 31172445
    [Abstract] [Full Text] [Related]

  • 13. Clinical characteristics and surgical outcome in hepatocellular carcinoma without hepatitis B virus surface antigen or hepatitis C virus antibody.
    Tanaka K, Shimada H, Matsuo K, Nagano Y, Endo I, Togo S.
    Ann Surg Oncol; 2007 Mar 01; 14(3):1170-81. PubMed ID: 17195904
    [Abstract] [Full Text] [Related]

  • 14. The Impact of the Hepatitis B Core Antibody Status on Recurrence in Patients with Non-B Non-C Hepatocellular Carcinoma after Curative Surgery.
    Okamura Y, Sugiura T, Ito T, Yamamoto Y, Ashida R, Uesaka K.
    Dig Surg; 2018 Mar 01; 35(3):243-251. PubMed ID: 28810252
    [Abstract] [Full Text] [Related]

  • 15. Clinical characteristics of non-B non-C hepatocellular carcinoma: a single-center retrospective study.
    Kim SK, Marusawa H, Eso Y, Nishikawa H, Ueda Y, Kita R, Kimura T, Chiba T, Osaki Y, Kudo M.
    Digestion; 2011 Mar 01; 84 Suppl 1():43-9. PubMed ID: 22156485
    [Abstract] [Full Text] [Related]

  • 16. Serum antibody titers against hepatitis C virus and postoperative intrahepatic recurrence of hepatocellular carcinoma.
    Uemura M, Sasaki Y, Yamada T, Gotoh K, Eguchi H, Yano M, Ohigashi H, Ishikawa O, Imaoka S.
    Ann Surg Oncol; 2014 May 01; 21(5):1719-25. PubMed ID: 24464342
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prognostic impact of hepatectomy for patients with non-hepatitis B, non-hepatitis C hepatocellular carcinoma.
    Ochiai T, Ogino S, Ishimoto T, Toma A, Yamamoto Y, Morimura R, Ikoma H, Otsuji E.
    Anticancer Res; 2014 Aug 01; 34(8):4399-410. PubMed ID: 25075077
    [Abstract] [Full Text] [Related]

  • 19. HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma.
    Sohn W, Paik YH, Kim JM, Kwon CH, Joh JW, Cho JY, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    Ann Surg Oncol; 2014 Jul 01; 21(7):2429-35. PubMed ID: 24619495
    [Abstract] [Full Text] [Related]

  • 20. Prediction of Hepatocellular Carcinoma Recurrence in Patients With Low Hepatitis B Virus DNA Levels and High Preoperative Hepatitis B Surface Antigen Levels.
    Huang G, Lau WY, Zhou WP, Shen F, Pan ZY, Yuan SX, Wu MC.
    JAMA Surg; 2014 Jun 01; 149(6):519-27. PubMed ID: 24696192
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.